Evidence and advocacy: are all things considered?

Affiliations

Comment

Jeffrey A Johnson et al. CMAJ. 2006.

. 2006 Jun 20;174(13):1856.

doi: 10.1503/cmaj.060231.

¹ Department of Public Health Sciences, University of Alberta and Institute of Health Economics, Edmonton, Alta. jeff.johnson@ualberta.ca

No abstract available

Comment on

Clinical practice guidelines and conflict of interest.
[No authors listed] [No authors listed] CMAJ. 2005 Nov 22;173(11):1297, 1299. doi: 10.1503/cmaj.051423. CMAJ. 2005. PMID: 16301688 Free PMC article. No abstract available.
The Canadian Diabetes Association guidelines: putting the evidence first.
Howlett MC, Lillie D. Howlett MC, et al. CMAJ. 2006 Jan 31;174(3):333-4. doi: 10.1503/cmaj.051556. CMAJ. 2006. PMID: 16446474 Free PMC article. No abstract available.
On bias and transparency in the development of influential recommendations.
Laupacis A. Laupacis A. CMAJ. 2006 Jan 31;174(3):335-6. doi: 10.1503/cmaj.051622. CMAJ. 2006. PMID: 16446476 Free PMC article. No abstract available.

1. Clinical practice guidelines and conflict of interest [editorial; published erratum in CMAJ 2005;174(1):167]. CMAJ 2005;173(11):1297, 1299. - PMC - PubMed
1. Howlett MC, Lillie D. The Canadian Diabetes Association guidelines: putting the evidence first. CMAJ 2006;174(3):333-4. - PMC - PubMed
1. Laupacis A. On bias and transparency in the development of influential recommendations. CMAJ 2006;174(3):335-6. - PMC - PubMed
1. Canadian Diabetes Association. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998;159(Suppl 8):S1-29. - PMC - PubMed
1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. 2003 clinical practice guidelines for the prevention and treatment of diabetes. Can J Diabetes 2003;27:Suppl 2.